Hi, what are you looking for?
Jewish Business News
Search results for " Erez Vigodman"
Business
The FTC has been investigating Valeant for potentially cornering a portion of the lens market.
Business
Teva Pharmaceutical Industries Ltd has announced today two offerings totaling approximately $6.75 billion of ordinary and preferred shares to fund its takeover of Allergan Plc’s...
Business
Teva to Receive Worldwide Development and Commercial Rights to Novel CGRP Antagonists; Heptares to Receive $10 Million Upfront with up to $400 Million in...
Mergers & Acquisitions
Generic drug maker Mylan $26bn hostile bid for peer Perrigo looked unlikely to succeed, a few hours before it was set to expire, a...
Business
Perrigo Company Plc, the Irish-based generic drugmaker trying to fend off a hostile bid by Mylan NV, held unsuccessful talks to acquire Endo International...
Business
Teva will become a leading pharmaceutical company in Mexico, the second largest market in Latin America and one of the top five emerging markets...
Business
Trying to fend off a hostile takeover attempt by Mylan’s $27 billion bid, Perrigo Chairman, President and CEO Joseph Papa sent a letter...
Business
Mylan N.V. (NASDAQ: MYL) shareholders have approved Mylan’s proposed acquisition of Perrigo Company plc (NYSE: PRGO; TASE). The transaction received the approval of two-thirds of...
Business
Joseph Papa scathingly dismisses Mylan's latest tactic in lowering the stake it wants to buy in Perrigo. "today's announcement makes it even worse"
Business
The acquisition gives Teva exclusive rights to Immuneering's cutting-edge analytics to advance treatments for diseases of the CNS.